Loading viewer...
conference
Format: PDF conference
Abcam is a leader in life science research reagents with £362M in 2022 revenues and adjusted gross margins exceeding 75%. The company generates 100% recurring revenues with 67% derived from in-house products and maintains complete exposure to the life sciences market. This presentation outlines Abcam's resilient growth strategy amid challenging market conditions.
case-study
conference
45 Pages
ANZ Group Holdings Limited
Adani Transmission Limited 2022 Asian Credit Conference Presentation
conferenceconference
40 Pages
Adani Transmission Limited